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SUPPLEMENTARY MATERIALS
Supplementary Table 1: Sensitivity analysis among none or mild prostatitis patients (N=5025)
Abbreviations: 95% CI, 95% confidence interval; OR odds ratio.
*Adjusted for baseline age, race, region, DRE (digital rectal examination), prostate volume, PSA (prostate-specific antigen), smoking, aspirin/
NSAID use, and biopsy results.
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Supplementary Table 2: Association between Baseline Inflammation and Race Stratified by NSAID use
The interaction between each race and NSAID use were all p≥0.072 for acute inflammation and p≥0.348 for chronic 
inflammation
Abbreviations: 95% CI, 95% confidence interval; OR odds ratio.
*Adjusted for baseline age, race, region, DRE (digital rectal examination), prostate volume, PSA (prostate-specific antigen), 
smoking, aspirin/NSAID use, and biopsy results.
